Concepedia

Maximilian A. Ardelt

MA

6

Publications

284

Citations

6

H-Index

2015

Active since

Affiliations

Ludwig-Maximilians-Universität München(Current)

Paracelsus Medical University

LMU Klinikum

Saarland University

Center for Integrated Protein Science Munich

Maximilian A. Ardelt is an author at Ludwig-Maximilians-Universität München specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2015–2022

6

Publications

6

Targeting cyclin dependent kinase 5 in hepatocellular carcinoma – A novel therapeutic approach

Sandra M. Ehrlich, Johanna Liebl, Maximilian A. Ardelt et al. · Journal of Hepatology · 2015 · 80 citations

, , +6

Inhibition of Cyclin‐Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy

Maximilian A. Ardelt, Thomas Fröhlich, Emanuele Martini et al. · Hepatology · 2018 · 67 citations · Full text

, , +16

PI(18:1/18:1) is a SCD1-derived lipokine that limits stress signaling

Maria Thürmer, André Gollowitzer, Helmut Pein et al. · Nature Communications · 2022 · 62 citations · Full text

Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria

Gundula Rendl, Brigitte Sipos, Alexander Becherer et al. · International Journal of Endocrinology · 2020 · 35 citations · Full text

Metabolic implication of tigecycline as an efficacious second‐line treatment for sorafenib‐resistant hepatocellular carcinoma

Martina Meßner, Sabine Schmitt, Maximilian A. Ardelt et al. · The FASEB Journal · 2020 · 22 citations · Full text

, , +18

Rows per page

1–5 of 6